journal article·2024-09

Reversing EZH2‐Mediated Epigenetic Silence with Photodynamic Polymeric Nanoparticles for Synergistically Enhanced Antitumor Immunotherapy

Lei Cao, Dongsheng Tang, Zhen Yu, Yue Shen, Yang Wang, Yue‐Qin Li, Juan Chen, Zhao‐Qian Liu, Ji‐Ye Yin, Haihua Xiao, Xiang‐Ping Li

Advanced Functional Materials· Volume 34· Issue 39
Publisher page

Abstract

Abstract Endogenous T cell activation relies on recognizing tumor‐specific antigens. However, tumor cells often alter phenotypes to evade immune surveillance, resulting in immune escape and drug resistance. Photodynamic therapy (PDT) activates anti‐tumor immune responses by generating reactive oxygen species, which induce endoplasmic reticulum stress and immunogenic cell death. The clinical application of PDT is limited by immunosuppressive tumor microenvironment. Notably, enhancer of zeste homolog 2 (EZH2) regulates expression of immune‐related genes in tumor and immune cells through H3K27 methylation. Consequently, targeting EZH2‐mediated epigenetic silence provides an effective strategy to enhance the anti‐tumor immune effect of PDT. In this study, a nano‐delivery system (NP2) is designed to demonstrate PDT and epigenetic reprogramming effects. NP2 can reverse epigenetic silence, enhance MHC‐I expression, and induce release of CXCL9‐10 via EZH2i. Meanwhile, NP2 has a significant effect on PDT, inducing endoplasmic reticulum stress that resulted in immunogenic cell death and subsequent activation of the immune cascade. In a mouse model of in situ breast cancer, the combination of PDT activation and epigenetic reprogramming through EZH2i showed synergistic effects on remolding, and triggering a robust anti‐tumor immune response in vivo. This study provides a novel idea for improving the immunosuppressive environment in clinical individualized immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Advanced Photocatalysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy Xiangya Hospital Central South University Changsha Hunan 410008 P. R. China

Department of Clinical Pharmacology Xiangya Hospital Central South University Changsha 410008 P. R. China

National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha 410008 P. R. China

Institute of Clinical Pharmacology Hunan Key Laboratory of Pharmacogenetics Central South University Changsha 410008 P. R. China

Engineering Research Center of Applied Technology of Pharmacogenomics Ministry of Education 110 Xiangya Road Changsha 410008 P. R. China

Beijing National Laboratory for Molecular Sciences State Key Laboratory of Polymer Physics and Polymer Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing 100190 P. R. China

Institute of Integrative Medicine Department of Integrated Chinese and Western Medicine Xiangya Hospital Central South University Changsha 410008 P. R. China

Funding

National Natural Science Foundation of China

References (59)

Show source-provided references
1. 10.1186/s13045-021-01164-510.1186/s13045-021-01164-5 ↗
2. 10.1016/j.canlet.2023.21621910.1016/j.canlet.2023.216219 ↗
3. 10.1038/s41568-021-00339-z10.1038/s41568-021-00339-z ↗
4. 10.1186/s13045-023-01492-810.1186/s13045-023-01492-8 ↗
5. 10.1126/sciimmunol.abd434410.1126/sciimmunol.abd4344 ↗
6. 10.1016/j.ccell.2023.04.01610.1016/j.ccell.2023.04.016 ↗
7. 10.1038/s41467-023-40850-510.1038/s41467-023-40850-5 ↗
8. 10.1186/s12943-022-01561-510.1186/s12943-022-01561-5 ↗
9. 10.1038/s41467-021-27349-710.1038/s41467-021-27349-7 ↗
10. 10.1126/science.abg578410.1126/science.abg5784 ↗
11. 10.1186/s12943-021-01464-x10.1186/s12943-021-01464-x ↗
12. 10.1126/science.aaw383510.1126/science.aaw3835 ↗
13. 10.1007/s13238-021-00846-710.1007/s13238-021-00846-7 ↗
14. 10.1038/s41588-020-00736-410.1038/s41588-020-00736-4 ↗
15. 10.1158/0008-5472.CAN-20-214710.1158/0008-5472.CAN-20-2147 ↗
16. 10.1016/j.it.2020.08.01010.1016/j.it.2020.08.010 ↗
17. 10.1038/nature0443110.1038/nature04431 ↗
18. 10.1038/s41568-021-00357-x10.1038/s41568-021-00357-x ↗
19. 10.1038/s41556-022-00850-x10.1038/s41556-022-00850-x ↗
20. 10.1073/pnas.210271811810.1073/pnas.2102718118 ↗
21. 10.1038/s41568-021-00386-610.1038/s41568-021-00386-6 ↗
22. 10.1038/s41571-021-00507-y10.1038/s41571-021-00507-y ↗
23. 10.1038/s41586-022-04772-410.1038/s41586-022-04772-4 ↗
24. 10.1126/science.aao050510.1126/science.aao0505 ↗
25. 10.1002/anie.20230066210.1002/anie.202300662 ↗
26. 10.1016/j.biomaterials.2022.12185610.1016/j.biomaterials.2022.121856 ↗
27. 10.1002/EXP.2022016110.1002/EXP.20220161 ↗
28. 10.1016/j.it.2022.04.01010.1016/j.it.2022.04.010 ↗
29. 10.1021/acsami.3c0469210.1021/acsami.3c04692 ↗
30. 10.1002/adma.20230004810.1002/adma.202300048 ↗
31. 10.1038/s41557-023-01242-w10.1038/s41557-023-01242-w ↗
32. 10.1039/D2NR06692K10.1039/D2NR06692K ↗
33. 10.1021/acs.nanolett.3c0019110.1021/acs.nanolett.3c00191 ↗
34. 10.1002/EXP.2023002710.1002/EXP.20230027 ↗
35. 10.1039/D0SC00785D10.1039/D0SC00785D ↗
36. 10.1038/s41467-020-18657-510.1038/s41467-020-18657-5 ↗
37. 10.1002/anie.20201247710.1002/anie.202012477 ↗
38. 10.1002/adma.20231029810.1002/adma.202310298 ↗
39. 10.1021/acsnano.9b0209610.1021/acsnano.9b02096 ↗
40. 10.1002/adma.20210665410.1002/adma.202106654 ↗
41. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
42. 10.1016/j.biomaterials.2022.12195210.1016/j.biomaterials.2022.121952 ↗
43. 10.1002/adma.20220979910.1002/adma.202209799 ↗
44. 10.1038/s41467-023-40826-510.1038/s41467-023-40826-5 ↗
45. 10.1002/adma.20220382010.1002/adma.202203820 ↗
46. 10.1039/D0CS01370F10.1039/D0CS01370F ↗
47. 10.2217/epi-2020-018610.2217/epi-2020-0186 ↗
48. 10.1126/sciadv.abo804310.1126/sciadv.abo8043 ↗
49. 10.1016/S1470-2045(18)30145-110.1016/S1470-2045(18)30145-1 ↗
50. 10.1038/s41467-021-26502-610.1038/s41467-021-26502-6 ↗
51. 10.1038/s41467-018-05078-810.1038/s41467-018-05078-8 ↗
52. 10.1038/s41568-020-0273-y10.1038/s41568-020-0273-y ↗
53. 10.1038/s41573-020-0077-510.1038/s41573-020-0077-5 ↗
54. 10.1126/sciadv.ade418610.1126/sciadv.ade4186 ↗
55. 10.1016/j.tibs.2019.03.00410.1016/j.tibs.2019.03.004 ↗
56. 10.1038/s41467-019-12318-y10.1038/s41467-019-12318-y ↗
57. 10.1038/s41565-022-01177-210.1038/s41565-022-01177-2 ↗
58. 10.1158/2159-8290.CD-18-109010.1158/2159-8290.CD-18-1090 ↗
59. 10.1016/j.bbcan.2022.18870010.1016/j.bbcan.2022.188700 ↗